Janet Alvarez

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• Enhancing chemotherapy response prediction via matched colorectal tumor-organoid gene expression analysis and network-based biomarker selection.
  2025 L1 78/100

1 assessed by us (1 reproduced) · 21 not yet assessed — every PubMed paper on record, linked below.

• Tumor-informed circulating tumor DNA stratifies recurrence risk and survival in anal squamous cell carcinoma ↗

  Nature Communications · 2026 · PMID 41748568
  not yet assessed
• Mastering rectal cancer MRI: From foundational concepts to optimal staging ↗

  European Journal of Radiology · 2025 · PMID 39864243
  not yet assessed
• Utilizing Patient Input in Rectal Cancer Trial Design ↗

  JNCI Journal of the National Cancer Institute · 2025 · PMID 40108482
  not yet assessed
• Assessment of morbidity and predictors of wound complications following perineal wound closure after radical anorectal oncologic resection: retrospective cohort study ↗

  BJS Open · 2025 · PMID 40503607
  not yet assessed
• Enhancing chemotherapy response prediction via matched colorectal tumor-organoid gene expression analysis and network-based biomarker selection

  Translational Oncology · 2025 · PMID 39754813
  L1 78/100
• Clinical and Genomic Characterization of Secondary Rectal Cancer After Radiotherapy for Prostate Cancer ↗

  JAMA Network Open · 2025 · PMID 40100215
  not yet assessed
• Circulating tumor DNA as an early response indicator in anal squamous cell carcinoma treated with chemoradiation. ↗

  Journal of Clinical Oncology · 2025
  not yet assessed
• Integrating Tumor and Organoid DNA Methylation Profiles Reveals Robust Predictors of Chemotherapy Response in Rectal Cancer ↗

  medRxiv · 2025 · PMID 40093220
  not yet assessed
• Abstract 5026: Discovery of oncogenic mediator genes in rectal cancer chemotherapy response using gene expression data from matched tumor and patient-derived organoids ↗

  Cancer Research · 2025
  not yet assessed
• Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer ↗

  BMC Cancer · 2024 · PMID 39060961
  not yet assessed
• Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer ↗

  2024
  not yet assessed
• ALLIANCE A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer ↗

  medRxiv · 2024 · PMID 38712176
  not yet assessed
• Enhancing Chemotherapy Response Prediction via Matched Colorectal Tumor-Organoid Gene Expression Analysis and Network-Based Biomarker Selection ↗

  medRxiv · 2024 · PMID 38343861
  not yet assessed
• Discovery of Oncogenic Mediator Genes in Rectal Cancer Chemotherapy Response using Gene Expression Data from Matched Tumor and Patient-Derived Organoid ↗

  medRxiv · 2024 · PMID 38352407
  not yet assessed
• An online rectal cancer tumoroid biorepository: A resource to facilitate multimodal data integration. ↗

  Journal of Clinical Oncology · 2024
  not yet assessed
• Watch-and-Wait Approach to Rectal Cancer: The Role of Imaging ↗

  Radiology · 2023 · PMID 36880951
  not yet assessed
• Anorectal mucosal melanoma ↗

  Seminars in Colon and Rectal Surgery · 2023 · PMID 38746826
  not yet assessed
• Organ preservation and total neoadjuvant therapy for rectal cancer: Investigating long-course chemoradiation versus short-course radiation therapy. ↗

  Journal of Clinical Oncology · 2023
  not yet assessed
• Circulating tumor DNA (ctDNA) for response assessment in patients with anal cancer treated with definitive chemoradiation. ↗

  Journal of Clinical Oncology · 2023
  not yet assessed
• Circulating tumor DNA (ctDNA) to assess response in patients with anal cancer treated with definitive chemoradiation. ↗

  Journal of Clinical Oncology · 2023
  not yet assessed
• Organ preservation and total neoadjuvant therapy for rectal cancer: Investigating long course chemoradiation versus short course radiation therapy. ↗

  Journal of Clinical Oncology · 2023
  not yet assessed
• Effect of Long-Term Mesalamine Therapy on Cancer-Associated Gene Expression in Colonic Mucosa of Patients with Ulcerative Colitis ↗

  Digestive Diseases and Sciences · 2018 · PMID 30478770
  not yet assessed